As of January 22, 2025, Atea Pharmaceuticals (AVIR) has a market cap of $0.26 billion USD. According to our data, Atea Pharmaceuticals is ranked No.6830 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 22, 2025 | $0.26 B |
-6.87%
|
Dec 31, 2024 | $0.28 B |
9.84%
|
Dec 29, 2023 | $0.26 B |
-36.59%
|
Dec 30, 2022 | $0.41 B |
-46.20%
|
Dec 31, 2021 | $0.76 B |
-78.60%
|
Dec 31, 2020 | $3.53 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Gilead Sciences
GILD
|
$115.95 B |
0.002 M
|
USA
|
Moderna
MRNA
|
$14.82 B |
-0.000 M
|
USA
|
Pfizer
PFE
|
$147.43 B |
0.004 M
|
USA
|
Merck
MRK
|
$242.01 B |
0.005 M
|
USA
|
Johnson & Johnson
JNJ
|
$349.71 B |
-0.006 M
|
USA
|
Regeneron Pharmaceuticals
REGN
|
$74.73 B |
1.236 B
|
USA
|
BioNTech
BNTX
|
$27.61 B |
0.000 M
|
Germany
|
Novavax
NVAX
|
$1.41 B |
-0.000 M
|
USA
|
GlaxoSmithKline
GSK
|
$68.21 B |
-0.002 M
|
UK
|
AstraZeneca
AZN
|
$211.49 B |
0.007 M
|
UK
|
Sanofi
SNY
|
$129.14 B |
0.001 M
|
France
|
AbbVie
ABBV
|
$298.91 B |
0.013 M
|
USA
|
Amgen
AMGN
|
$146.98 B |
0.004 M
|
USA
|
Eli Lilly
LLY
|
$677.80 B |
-0.006 M
|
USA
|
Market Cap | = | AVIR Stock Price | * | AVIR Shares Outstanding |
= | $3.12 | * | 84.46 M | |
= | $0.26 B |